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Chandigarh and 4) Department of Anesthesia, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, IndiaAbstractNosocomial infections are acquired during hospital treatment or in a hospital environment. One such infecting agent, Escherichia coli, harbours
many virulence genes that enable it to become pathogenic, causing damage to the host. The mechanism of the E. coli virulence factors
provenance to cause infection in host environments is not clearly elucidated. We investigated the virulence and pathogenicity of E. coli
affected by the host environment. For this, blood (n = 78) and faecal (n = 83) E. coli isolates were collected from patients with and
without sepsis, respectively, who had been admitted to the intensive care unit. The E. coli genomic DNA was isolated; the phylogenetic
grouping was conducted by triplex PCR. The occurrence of nine virulence genes among the all the isolates was conﬁrmed by gene-
speciﬁc PCR. The prevalence of E. coli in blood isolates was more in phylogenetic groups B2 and D compared to groups A and B1.
However, in faecal isolates, there was no signiﬁcant difference. The prevalence of adhesin and toxin (papG, sfa, afa, cnf1, hlyA) genes was
higher in blood compared to faecal E. coli isolates. However, the prevalence of aer, traT and PAI was similar as well as higher among both
of these groups. These observations indicate a role of external environment (hospital setting) on host susceptibility (development of
infection) in the faecal E. coli isolates, thereby making the patient prone to a sepsis condition.
© 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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E-mail: myadav@acbr.du.ac.inIntroductionNosocomial infections are the major cause of death and
increased morbidity among hospitalized patients. The incidence
of such infections is estimated to be 5–10% of patients admitted
to tertiary care hospitals, although this may go up to 28% in the
intensive care unit (ICU). Nosocomial infections contribute to
0.7–10% of deaths compared to 0.1–4.4% of all the deaths
occurring in hospitals [1]. Alarmingly, 10–30% of patients in the© 2015 New Microbes and New Infections published by El
This is an open access artiIndian population acquire such infections [1]. Nosocomial in-
fections are most commonly acquired as a result of surgical
wounds, urinary tract infections (UTIs) and lower respiratory
tract infections and may be cross-infections or endogenous.
Modern diagnostic procedures such as biopsies, endoscopic
examinations, catheterization, intubation/ventilation and surgi-
cal procedures increase the risk of infection by microorganisms
like Escherichia coli that are normally innocuous but may
become pathogenic when the body’s immunological defenses
are compromised [1].
E. coli is the most common pathogen causing diarrhoea,
neonatal septicemia, UTI, bacteraemia and urosepsis [2]. It is
responsible for 80% of community-acquired UTIs and 30% of
nosocomial infections [3]. E. coli is one of the leading causes of
bloodstream infections and comprises 17–37% of all bacteria
isolated from patients with bloodstream infections [4]. SuchNew Microbe and New Infect 2015; 7: 57–66
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associated with patients who have undergone major surgeries;
who were admitted to hospitals for long durations; or who had
a peripheral or urinary catheter [1]. E. coli in the bloodstream
can trigger vigorous host inﬂammatory response, leading to
sepsis associated with high morbidity and mortality [5].
A phylogenetic analysis indicates discrete origins of a diverse
natural populations of the pathogenic E. coli [6] that can be
classiﬁed into major phylogenetic groups A, B1, B2 and D [7].
The commensal strains usually belong to groups A and B1,
whereas the extraintestinal pathogenic strains belong to groups
B2 and D [8,9]. The intestinal E. coli are mixture of all the
phylogenetic groups and may act as a reservoir for the patho-
genic isolates. The pathogenicity of intestinal or extraintestinal
E. coli may be attributed to its genetic virulence markers [10].
Strains of groups B2 and D often carry virulence factors (VFs)
that are lacking in A and B1 [8,11,12]. The reason for a
commensal strain becoming virulent may be attributed to the
multiple strategies of genome plasticity wherein the random
point mutations were incorporated for adaptive pathogenic
environments [13]. The VFs in E. coli are required to overcome
host defenses, invade host tissues and trigger a local inﬂam-
matory response. E. coli virulence and phylogeny are inter-
twined because VFs from both the host and the environment
shape its genetic structure [14].
To date, no single virulence factor has been demonstrated as
being speciﬁc, unique or deﬁnitive to cause a particular disease.
Virulence is multifactorial because it depends on both the
characteristics of microbe and the susceptibility of the host
[15]. On the basis of functional groups, the E. coli VFs can be
categorized as adhesins, such as P ﬁmbriae (papG), type 1
ﬁmbriae (ﬁmH), S ﬁmbriae (sfa) and A ﬁmbriae (afa); toxins,
such as hemolysin A (hlyA) and cytotoxic necrotizing factor 1
(cnf1); iron uptake, such as aerobactin (aer); protectins, such as
serum resistance (traT); and others, such as pathogenicity-
associated islands (PAIs) and Tir-containing protein of E. coli
(tcpc) [16–18]. PAIs have previously been investigated in path-
ogenic bacteria. However, to our knowledge, no study has been
conducted for commensal strains [19]. Houdouin et al. [20]
reported a susceptibility of the E. coli isolates from blood of
urosepsis patients to diverse antibiotics according to the
prevalence of VFs and phylogenetic groups.
The E. coli phylogenetic grouping and their correlation with
the VFs in disease conditions is well established [11,15,21];
however, a correlation between phylogenetic groups and
virulence proﬁle of the blood and faecal E. coli isolates is not
known. Most of the previous studies compared the virulence
properties of E. coli isolates from disease condition with those
from healthy individuals [11,15,22]; however, the potential of
faecal E. coli isolates (usually commensals) to cause the disease© 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Soc
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understand the host susceptibility, we investigated the blood
E. coli isolates from the patients diagnosed with sepsis and
compared them with the faecal E. coli isolates from patients
without sepsis admitted to the ICU. We found that the prev-
alence of the E. coli isolates among the pathogenic groups B2
and D was signiﬁcantly higher than the commensal groups A
and B1 in faecal E. coli isolates. The overall prevalence of E. coli
isolates among pathogenic groups was similar to commensal
groups faecal E. coli isolates, indicating that this group of patients
has a higher chance of contracting a severe form of infection. In
addition, an overall prevalence of VFs among all the phyloge-
netic groups was higher in the blood E. coli isolates. However,
the high prevalence of aer, traT and PAI among faecal E. coli
isolates indicated that the host environment may have an
important role to play for a differential expression of these
virulence genes to induce pathogenicity in the hospital setting.
A knowledge of such virulence patterns and their correlation
with phylogenetic groups is critical for our understanding of
bacterial infection and is indispensable to the development of
devising related novel therapeutic strategies.MethodsSelection of patients and bacterial isolates
Blood samples (n = 78) were collected from patients with sepsis
admitted to the ICU of Vardhman Mahavir Medical College
(VMCC) and Safdarjung Hospital, New Delhi, India, from
February 2011 to August 2013. The blood culture was carried
out as a part of compulsory diagnostic testing. The samples
were selected from patients who had shown a clinical response
arising from a nonspeciﬁc insult, which include more than two
of the following: multiple positive blood culture results;
bacteremia associated with systemic symptoms; temperature
>38.5°C; hypotension (systolic blood pressure <90 mm Hg);
and leucocytosis (white blood cell count 13 000/mm3). In
addition, randomly selected faecal samples (n = 83) were
collected from patients admitted to the ICU (on day 1) for
cardiovascular surgeries and road transport accidents who
were not diagnosed with sepsis at VMCC and Safdarjung Hos-
pital during the same period of time. A total of 161 blood and
faecal E. coli isolates (Table 1) were screened for E. coli positivity
by standard biochemical procedures. Only one isolate from
each patient is included in this study.
Subculturing of bacterial isolates and isolation of DNA
The E. coli isolates were grown as lactose-positive colonies on
MacConkey blood agar medium in the Department of Micro-
biology at VMCC and Safdarjung Hospital. Thereafter, theiety of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
nses/by-nc-nd/4.0/)
TABLE 1. Clinical diagnosis of 161 patients with and without
sepsis
Clinical diagnosis n (%)
Sepsis patients treated in ICU 78 (48.4)
Sepsis 19 (24.3)
UTI 9 (11.5)
Bronchopneumonia 10 (12.8)
Nephritic syndrome 8 (10.2)
NA (blood culture positive for Escherichia coli) 32 (41)
Nonsepsis patients treated in ICU 83 (51.6)
Medical device in patient’s body after major surgery
or patients underwent invasive procedurea
83 (100)
ICU, intensive care unit.
aPatients with cardiovascular surgeries and patients who experienced road trans-
port accidents who were not diagnosed with sepsis.
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at 37°C for 18 hours. A portion of the broth containing bac-
terial isolates was pooled and processed for isolation of the
bacterial genomic DNA by the standard sodium acetate pre-
cipitation method. DNA was quantiﬁed using NanoDrop
(NanoDrop ND 100).
Triplex PCR
A triplex PCR was performed using a bacterial genomic DNA
as template and primers speciﬁc to chuA and yjaA genes and the
TSPE4.C2 DNA fragment, as described elsewhere [7] (Table 2).
For PCR ampliﬁcation, a 25 μL reaction containing 1 μL tem-
plate DNA, 2 mM MgCl2, 0.5 mM dNTPs, 0.5YU of Taq poly-
merase (Promega) and 0.3 pmol/μL of forward and reverse
primers each in 1× PCR buffer was set up. The reaction con-
ditions included one cycle of initial denaturation for 5 minutes
at 94°C and thereafter 35 cycles of denaturation for 30 seconds
at 94°C, annealing for 30 seconds at 55°C and an extension of 5TABLE 2. Primers for ampliﬁcation of Escherichia coli genes related
Functional Category Gene Oligonucleotide sequence (50 –30) An
Phylogenetic grouping
chuA f GACGAACCAACGGTCAGGAT
r TGCCGCCAGTACCAAAGACA
55
YjaA f TGAAGTGTCAGGAGACGCTG
r ATGGAGAATGCGTTCCTCAAC
55
TspE4.C2 f GAGTAATGTCGGGGCATTCA
r CGCGCCAACAAAGTATTACG
55
Virulence factors
Adhesins papG f GCATTTCTACGGTAACC
r TCGTCAAATTTCTCAGTCAGA
50
Sfa f CTCCGGAGAACTGGGTGCATCTTAC
r CGGAGGAGTAATTACAAACCTGGCA
54
Afa f GCTGGGCAGCAAACTGATAACTCTC
r CATCAAGCTGTTTGTTCGTCCGCCG
60
ﬁmH f TGCAGAACGGATAAGCCGTGG
r GCAGTCACCTGCCCTCCGGTA
55
Toxins hlyA f AACAAGGATAAGCACTGTTCTGGCT
r ACCATATAAGCGGTCATTCCCGTCA
55
cnf1 f AAGATGGAGTTTCCTATGCAGGAG
r CATTCAGAGTCCTGCCCTCATTATT
52
Iron uptake aer f TACCGGATTGTCATATGCAGACCGT
r AATATCTTCCTCCAGTCCGGAGAAG
56
Protectins/serum resistance traT f GGTGTGGTGCGATGAGCACAG
r CACGGTTCAGCCATCCCTGAG
57
Pathogen associated island PAI f GGACATCCTGTTACAGCGCGCA
r TCGCCACCAATCACAGCCGAAC
57
© 2015 New Microbes and New Infections published by Elsevier Ltd on beha
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carried out before termination. Thereafter the PCR products
were run on 1.8% agarose gel (Saekem Lonza). All the strains
were tested in triplicate with positive and negative controls.
The positive control was E. coli strain CFTO73 obtained from
ATCC (no. 700928), and the negative control was PCR master
mix without DNA template.
Phylogenetic grouping
A phylogenetic grouping (A, B1, B2 and D) of E. coli isolates
from patients with and without sepsis was determined on the
basis of triplex PCR data by making a dichotomous decision
tree based on an ampliﬁcation of chuA and yjaA genes and the
TSPE4.C2 DNA fragment, as previously reported [7]. The
fragment size of the chuA and yjaA genes and the TSPE4.C2
DNA fragment was 279, 211 and 152 bp, respectively. Group
B2 was designated with a positivity of chuA and yjaA genes;
group D with a positivity of chuA gene and a negativity of yjaA
gene; group B1 with a positivity of TspE4.C2 DNA fragment
and a negativity of chuA gene; and group A with a negativity of
chuA gene and TspE4.C2 DNA fragment.
PCR for virulence markers
The presence of virulence genes encoding P ﬁmbriae (papG), type
1 ﬁmbriae (ﬁmH), S ﬁmbriae (sfa), A ﬁmbriae (afa), cytotoxic
necrotizing factor 1 (cnf1), hemolysin (hlyA), aerobactin (aer),
serum resistance (traT) and pathogenicity-associated island
marker (PAI) was evaluated by performing a PCR using gene-
speciﬁc primers (Table 2). Using a bacterial genomic DNA from
patients with and without sepsis as the template, a PCR ampliﬁ-
cation was performed for each gene in a standard 25 μL reaction.to phylogenetic grouping and virulence genes
nealing temperature (°C) Product size (bp) Reference
279 Clermont et al. 2000 [7]
211
152
295 Norinder et al. 2012 [40]
408 Le Bouguenec et al 1992 [41]
793 Le Bouguenec et al. 1992 [41]
506 Johnson & Stell 2000 [22]
1177 Yamamoto et al 1995 [42]
498 Kuhar et al 1998 [43]
602 Yamammoto et al 1995 [44]
288 Johnson and Stell 2000 [22]
922 Johnson and Stell 2000 [22]
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for 5 minutes at 94°C and thereafter 35 cycles of denaturation for
30 seconds at 94°C, annealing for 30 seconds at speciﬁc tem-
perature (Table 2) and an extension of 5 minutes at 72°C. A ﬁnal
extension of 10 minutes at 72°C was carried out before termi-
nation. Thereafter the PCR products were run on 1.8% agarose
gel (Saekem Lonza). All the strains were tested in triplicate with
positive and negative controls. The positive control was E. coli
strain CFTO73 obtained from ATCC (no. 700928), and the
negative control was PCR master mix without DNA template.
Statistical analysis
The Z test was used to compare the virulence factor’s preva-
lence among the blood and faecal E. coli isolates. A one-way
ANOVA nonparametric test was performed to analyse the
virulence proﬁle among various E. coli phylogenetic groups. A p
value of <0.05 was considered signiﬁcant.
Ethical clearance
The isolates were previously approved by the Institutional
Ethical Committee of Vardhman Mahavir Medical College
(VMCC) and Safdarjung Hospital, New Delhi, India (S.No-
VMMC/SJH/Ethics/SEP-11/29). As per the guidelines, an
informed written consent was taken from all the adult subjects
included in this study.ResultsPhylogenetic grouping of blood and faecal E. coli
isolates
E. coli commensal strains belong to groups A and B1, whereas
extraintestinal pathogenic strains belong to groups B2 and D© 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Soc
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of phylogenetic groups A (19.2%), B1 (26.5%), B2 (30%) and D
(24%) (p 0.47) (Fig. 1, Table 3) in the faecal E. coli isolates,
whereas phylogenetic groups B2 (25.6%) and D (47.4%) were
found to be more prevalent (p 0.0001) among the blood E. coli
isolates (Fig. 1, Table 3). Individually, we did not ﬁnd any sig-
niﬁcant difference in the prevalence of phylogenetic group A in
blood (17%) and faecal (19.2%) E. coli isolates; however, group
B1 was found to be signiﬁcantly higher in the faecal E. coli iso-
lates (p 0.0008) (Fig. 1, Table 3), as previously described [23].
Contrary to expectation, we did not ﬁnd any signiﬁcant dif-
ference in the prevalence of phylogenetic group B2 from blood
and faecal E. coli isolates. However, phylogenetic group D
(47.4%) was more prevalent in blood (p 0.002) compared to
faecal E. coli isolates (Fig. 1, Table 3), thus corroborating earlier
observations of extraintestinal pathogenic strains belonging to
group D [8,24,25].
Virulence proﬁle of blood and faecal E. coli isolates in
phylogenetic groups
E. coli phylogenetic grouping and its correlation with the VFs in
various disease conditions has been previously described
[11,21,22]. The combined virulence proﬁle of all the nine VFs
(papG, ﬁmH, sfa, afa, cnf1, hlyA, aer, traT and PAI) among the
phylogenetic groups (A, B1, B2 and D) of the blood E. coli
isolates was found to be signiﬁcantly higher than the faecal
isolates (p 0.002; Fig. 2A, dotted lines). Relatively higher levels
of VFs among the faecal E. coli isolates suggest the entry of
commensal E. coli into the bloodstream, thus enhancing its
pathogenicity.
We investigated a possible link between strain phylogeny
and individual virulence genes among blood and faecal E. coli
isolates. Our data showed that the adhesin coding genes PapGFIG. 1. Triplex PCR–based comparison
of prevalence of phylogenetic groups
between blood (n = 78) and faecal
(n = 83) Escherichia coli isolates. The p
value is calculated by Z test and indicate
signiﬁcance between blood and faecal
E. coli isolates.
iety of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
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TABLE 3. Distribution of phylogenetic groups and virulence
genes in blood and faecal Escherichia coli isolates from
patients with and without sepsis
Category/variable
No. (%) of isolates for:
p
Total
(n [ 161)
Sepsis,
blood
(n [ 78)
Nonsepsis,
faecal
(n [ 83)
Phylogenetic groups
Group A 29 (18) 13 (17) 16 (19.2) NS
Group B1 30 (18.6) 8 (10) 22 (26.5) 0.0008
Group B2 45 (27.9) 20 (25.6) 25 (30) NS
Group D 57 (35.4) 37 (47.4) 20 (24) 0.002
Virulence factors
Adhesins
P ﬁmbriae (papG) 114 (70.8) 75 (96) 39 (47) 0.0001
Type 1 ﬁmbriae (ﬁmH) 150 (93.2) 70 (90) 80 (96) NS
S ﬁmbriae (sfa) 92 (57.14) 65 (83) 27 (32.5) 0.0001
A ﬁmbriae (afa) 52 (32.2) 38 (49) 14 (17) 0.0001
Toxins
Hemolysin A (hlyA) 19 (11.8) 14 (18) 5 (6) 0.02
Cytotoxic necrotizing
factor (cnf1)
46 (28.6) 38 (49) 8 (10) 0.0001
Iron uptake
Aerobactin (aer) 110 (68.3) 53 (68) 57 (69) NS
Protectins
Serum resistance (traT) 136 (84.5) 63 (81) 73 (88) NS
Other
Pathogenicity associated
island (PAI)
80 (49.7) 36 (46) 44 (53) NS
NS = nonsigniﬁcant.
The p value is calculated by Z test and indicates signiﬁcance between patients with
and without sepsis.
NMNI Nagarjuna et al. Virulence proﬁle of sepsis E. coli 61and ﬁmH were the most prevalent (90–100%) among all the
phylogenetic groups in blood E. coli isolates, and ﬁmH was
equally (80–100%) high in the faecal isolates (Fig. 2B). A
signiﬁcant difference (p <0.0001) was observed in the prev-
alence of papG between blood and faecal E. coli isolates. The
overall prevalence of sfa in the blood E. coli isolates was
higher in groups B1 and B2 compared to groups A and D (p
<0.0001). Afa in the blood E. coli isolates was higher in groups
A and D compared to groups B1 and B2, whereas it was
varied for the faecal E. coli isolates. Of the toxin-coding genes
studied, the overall prevalence of cnf1 in the blood E. coli
isolates was higher in groups B1 and B2 compared to groups
A and D (p <0.0001), whereas hlyA was very low in both
groups.
A signiﬁcant difference was found in the prevalence of aer in
groups B1 and B2 (p <0.01) of blood and faecal E. coli isolates;
however, the reverse scenario was seen for the group D. The
prevalence of traT in groups B1, B2 and D was higher in faecal
E. coli isolates compared to blood isolates (p <0.05). The
prevalence of PAI in groups A and B1 was found to be higher in
the blood E. coli isolates (p <0.05); however, the prevalence of
group D was signiﬁcantly higher in faecal E. coli isolates (100%)
compared to the blood isolates (35%, p <0.002) (Fig. 2B).
Interestingly, an unexpected high expression of the virulence
genes among the faecal E. coli isolates indicates the role of these
genes in the development of infection.© 2015 New Microbes and New Infections published by Elsevier Ltd on beha
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isolates
The pathogenic E. coli possesses an array of VFs leading to its
pathogenesis [26]. The prevalence of the adhesin and toxin
categories—that is, papG, sfa, afa, cnf1 and hlyA among blood
E. coli isolates—was found to be signiﬁcantly higher than faecal
isolates, indicating their signiﬁcant association to the pathogenic
conditions (Fig. 3A, Table 3). However, no signiﬁcant difference
was observed in the prevalence of ﬁmH among the blood and
faecal E. coli isolates, as we expected. Surprisingly, no difference
was observed in the prevalence of aer, traT and PAI among the
blood and faecal E. coli isolates, indicating a role of the host
environment in stimulating the bacteria to acquire these viru-
lence genes (Fig. 3A, Table 3).
The prevalence of the E. coli isolates with respect to the
papG, sfa, afa, cnf1 and hlyA in the phylogenetic groups (A, B1,
B2 and D) belonging to the blood E. coli isolates was higher
compared to faecal E. coli isolates. However, no discrete dif-
ference in the prevalence of the E. coli isolates with respect to
aer, traT and PAI was observed among various phylogenetic
groups (Fig. 3B). Instead, a high prevalence of ﬁmH, aer, traT and
PAI among the faecal E. coli isolates suggests an effect of external
environment to induce bacterial pathogenicity [27].DiscussionCharacterization of E. coli is important for both clinical and
epidemiologic implications. A community- or hospital-acquired
E. coli infection is the primary cause of neonatal meningitis, UTI,
urosepsis and sepsis [11,21,24,28], but reports of E. coli causing
bloodstream infections are limited. The pathogenic E. coli strains
belong to phylogenetic groups B2 or D, out of which B2 isolates
are more prevalent among the intestinal pathogenic strains
whereas the commensal one belongs to group A or group B1
[8,16]. Irrespective of the presence or absence of virulence genes
or factors, the status of the host can be critical for the develop-
ment of an infection [29]. Studying bacterial isolates fromdifferent
diseased hosts like pyelonephritis, cystitis and asymptomatic
bacteriuria (ABU) is common, but for sepsis it is not known.
Pathogenic behaviour is predicted both by virulence factor
repertoire and by phylogenetic background [8,30]. Genetically,
extraintestinal pathogenic E. coli harbours a variety of VFs,
which gathered into pathogenicity-associated islands and
enhance the capacity of E. coli to cause systemic infections [31].
However, it is still not clear how strains with apparently low
virulence can cause sepsis, not only in compromised but also in
noncompromised hosts [32]. It is conceivable that these strains
may possess unrecognized VFs or speciﬁc VFs that may facilitate
bacteraemia [20]. Previous studies described papC and aer aslf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
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FIG. 2. (A) Combined prevalence of virulence factors among phylogenetic groups of blood and faecal Escherichia coli isolates. Dotted lines indicate
mean values among blood and faecal E. coli isolates. The p value is calculated by Z test and indicates signiﬁcance among both groups. (B) Expression of
virulence genes among phylogenetic groups in blood and faecal E. coli isolates.
62 New Microbes and New Infections, Volume 7 Number C, September 2015 NMNIthe minimal prerequisite for bacterial passage from kidney
infection into the bloodstream [21,33,34]. The role of E. coli VFs
in the pathogenesis of sepsis in relation to the site of its primary
infection is virtually unknown.
Virulence properties of the isolates belonging to phyloge-
netic groups A and B1 were not analysed. To understand the© 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Soc
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licerole of commensal intestinal E. coli as a potential source for
pathogenic and E. coli populations, we investigated the phylo-
genetic groups and virulence proﬁle of the blood and faecal
E. coli isolates from patients with and without sepsis, respec-
tively, admitted to the ICU. The faecal isolates were not
collected from the same sepsis patients because such patientsiety of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
nses/by-nc-nd/4.0/)
FIG. 3. PCR-based prevalence of virulence genes (papG, ﬁmH, sfa, afa, cnf1, hlyA, aer, traT, PAI) between blood (n = 78) and faecal (n = 83) Escherichia
coli isolates (A). Solid and empty shapes represent blood and faecal E. coli isolates, respectively (B). The p value is calculated by Z test and indicates
signiﬁcance among both the groups. *p 0.02; **p 0.0001; ns, nonsigniﬁcant.
NMNI Nagarjuna et al. Virulence proﬁle of sepsis E. coli 63will deﬁnitely have an effect on their gut ﬂora and would not
have acted as a suitable control. We established phylogenetic
grouping of E. coli isolates into four groups: A, B1, B2 and D [7].
No signiﬁcant difference was observed in the prevalence of the
commensal and pathogenic phylogenetic groups in the blood
and faecal E. coli isolates. However, group B1 was more prev-
alent in the faecal E. coli isolates, suggesting they may have been
acquired from the hospital environment by these patients. A
high prevalence of E. coli in the group D blood isolates© 2015 New Microbes and New Infections published by Elsevier Ltd on beha
This is an open access articorroborates the nature of the E. coli as an extraintestinal
pathogenic strain [8]. The aberrant observation of high preva-
lence of groups B2 among the faecal E. coli isolates may be
attributed to hospital-acquired infections. A collective high
prevalence (54%) of groups B2 and D among the faecal E. coli
isolates may be ascribed to the varied bacterial characteristics,
antibiotic usage or genetic factors of the host. The observed
difference in distribution of E. coli phylogenetic groups between
pathogenic and commensal E. coli populations was similar tolf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
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from different host population cohorts [30].
Because faecal ﬂora is considered to be the natural reservoir
of pathogenic strains in extraintestinal infections [35], the
phylogenetic distribution of commensal E. coli isolates from
healthy individuals could provide an important comparison of
and insight into the spread of the potential pathogenic lineage.
Previous reports indicated that group B2 E. coli strains are rare
in faecal samples [30], which is contrary to our data. This im-
plies that acquiring the group B2 strain in faecal samples is
important in the risk of infection. In a similar phylogenetic study
among patients with UTIs, group B2 dominated in the uropa-
thogenic strains, while they also accounted for about 50% of the
rectal specimen [35]. The high percentage of group B2 and
group D in the faecal E. coli isolates prompted us to ask how
frequently the virulent B2 pathogens that are routinely carried
by healthy humans would affect the disease dynamic in this
population.
In order to ﬁnd possible link between strain phylogeny and
individual virulence genes, we analysed an overall virulence
proﬁle (papG, ﬁmH, sfa, afa, cnf1, hlyA, aer, traT and PAI) of blood
and faecal E. coli isolates. The aggregate score of the virulence
was found to be higher in blood than in faecal E. coli isolates.
We observed a variable expression of virulence genes among
the commensal (A and B1) and pathogenic (B2 and D) groups of
blood and faecal E. coli isolates. An unexpected high expression
of the virulence genes among the faecal E. coli isolates indicated
a role of these genes in the development of infection and sug-
gested that the challenged host environment (such as the
presence of catheters or hospital-acquired infections, or even
poor hygiene due to infrequent urination of the patient, leading
to a high vulnerability) may have altered the bacterial patho-
genicity [1].
In E. coli extraintestinal infections, phylogenetic group B2
was found to be predominant and more virulent than other
phylogenetic groups. An ascending route was proposed to be
the major pathway of E. coli causing UTIs [36]. In addition to
the virulence factors, host factors such as obstructions and
immune-compromising conditions may favour the develop-
ment of UTI among such patients [37]. Out of the VFs
examined in this study, papG, sfa, afa, cnf1 and hlyA were
found to be more prevalent in the blood than the faecal
E. coli isolates. Our data suggest that the adhesin coding gene
ﬁmH was the most prevalent among all the phylogenetic
groups of blood and faecal E. coli isolates. FimH-mediated
bioﬁlm formation is known to facilitate bacterial coloniza-
tion of urinary catheters and other medical implants—an
unfortunately common problem for hospitalized individuals
[38]. An unexpected high expression of the virulence genes© 2015 New Microbes and New Infections published by Elsevier Ltd on behalf of European Soc
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceaer, traT and PAI among the faecal E. coli isolates indicates
their role in the development of infection. A high prevalence
of these virulence genes may have led to the entry of
commensal E. coli into the bloodstream, leading to sepsis
[21,33,34]. hlyA and traT are known to predict the bacterial
pathogenicity [39] among both compromised and non-
compromised hosts [22].
The prevalence of adhesin and toxin (papG, sfa, afa, cnf1
and hlyA) genes was signiﬁcantly higher in the E. coli isolates
from the blood compared to faecal E. coli isolates, indicating a
possible association to the pathogenic conditions [22]. The
high prevalence of adhesins in blood and faecal E. coli isolates
than the expression of toxins or other virulence factors is
arguably the most important determinant of pathogenicity.
Surprisingly, no difference was observed in the prevalence of
ﬁmH, Aer, traT and PAI among the E. coli isolates of both these
groups, indicating a role of the host environment in stimu-
lating the bacteria to acquire these VFs and thus inducing the
bacterial pathogenicity [26]. The analysis of virulence gene
expression suggested a variable prevalence of aer, traT and PAI
in the phylogenetic groups among blood and faecal E. coli
isolates. The unusual high prevalence of PAI in the faecal E. coli
isolates in our study indicates its role in making these patients
vulnerable to severe infection. These observations suggest
that the faecal E. coli isolates may transform a nonsepsis
condition into sepsis in a hospital environment. In addition,
the similar prevalence of aer, traT, and PAI in blood and faecal
E. coli isolates is contrary to the ﬁndings of previous studies in
E. coli strains from urosepsis [22].
In summary, we report for the ﬁrst time a correlation of
phylogenetic groups with important virulence markers in blood
and faecal E. coli isolates from patients with and without sepsis
admitted to the ICU. The high prevalence of all the VFs studied
in the blood and faecal E. coli isolates and a similar prevalence of
aer, traT and PAI indicate their role in the sustenance and
development of infection. The speciﬁc association of hlyA and
cnf1 in the blood and faecal E. coli isolates indicate that the host
environment may have an important role to play for a differ-
ential expression of virulence genes, thereby causing pathoge-
nicity among these isolates in hospital settings. Therefore, our
data suggest that faecal isolates could become pathogenic in the
immunocompromised patients under challenging host condi-
tions. Our study also indicates that patients prone to a severe
form of infection in the hospital environment may be identiﬁed
on the basis of their virulence proﬁle. Further investigation is
required to determine the interplay of these VFs and concur-
rently identifying the mechanisms regulating the expression of
these traits in sepsis and nonsepsis E. coli isolates in order to
improve the management of infectious diseases.iety of Clinical Microbiology and Infectious Diseases, NMNI, 7, 57–66
nses/by-nc-nd/4.0/)
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